H.R. 3415 · 116th Congress
Real-Time Beneficiary Drug Cost Bill
- Stage
- In committee
- Sponsor
- Elissa Slotkin
- Introduced
- 2019-06-21
- Latest action
- 2019-06-24 · Referred to the Subcommittee on Health.
Summary
Real-Time Beneficiary Drug Cost Bill
This bill provides statutory authority for certain provisions of the Centers for Medicare & Medicaid Services rule titled "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses," published on May 23, 2019. The rule requires, in part, Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that is capable of integrating with at least one prescriber's electronic prescribing system or electronic health record. The tool must provide prescribers with patient-specific, real-time formulary and benefit information, including information regarding cost-sharing, formulary alternatives, and utilization management requirements. The rule takes effect January 1, 2021.